Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas

Recruiting now

Conditions studied: Quality of Life, Meningioma

In brief

Meningiomas, which account for about 40% of primary central nervous system tumors, have significant psychological and social impacts, even without treatment. Their effect on quality of life is often underestimated and poorly documented. There is one validated questionnaire (MQOL) but it has not yet been translated into French. The project involves two phases: first, translating and linguistically validating the MQOL into French; second, scientifically validating the questionnaire with 50 meningioma patients using established scales (EQ-5D, Karnofsky, FACT-Br) to ensure its reliability and internal consistency.

Key facts

Study ID

NCT07044076

Run by

Centre Hospitalier St Anne

People needed

50

Starts

2025-06-13

Expected to finish

2025-12-12

Last updated by the study team

2025-06-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient aged 18 years or older
• Diagnosis of intracranial meningioma confirmed by imaging or surgery

You may not qualify if…

• Pregnant or breastfeeding women (Article L1121-5)
• Patients deprived of liberty by judicial or administrative decision, as well as individuals undergoing psychiatric care (Article L1121-6)
• Patients not fluent in French or with poor understanding of the language
• Inability to refuse participation in the study

Where it is running

• GHU Paris -Psychiatrie & Neurosciences — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.